Regulatory News
Thursday, June 2, 2016
EU regulators to rule on Mylan's $7.2 bln Meda bid by July 6
BRUSSELS, June 2 - European Union antitrust regulators will
rule by July 6 whether to allow U.S. generic drugmaker Mylan NV
to buy Swedish peer Meda or open a full-scale
investigation.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment